JS, O., GM, K., Orman, J. S., & Keating, G. M. (2009). Spotlight on buprenorphine/naloxone in the treatment of opioid dependence. CNS Drugs, 23(10), 899. https://doi.org/10.2165/11203740-000000000-00000
Chicago Style (17th ed.) CitationJS, Orman, Keating GM, Jennifer S. Orman, and Gillian M. Keating. "Spotlight on Buprenorphine/naloxone in the Treatment of Opioid Dependence." CNS Drugs 23, no. 10 (2009): 899. https://doi.org/10.2165/11203740-000000000-00000.
MLA (9th ed.) CitationJS, Orman, et al. "Spotlight on Buprenorphine/naloxone in the Treatment of Opioid Dependence." CNS Drugs, vol. 23, no. 10, 2009, p. 899, https://doi.org/10.2165/11203740-000000000-00000.
Warning: These citations may not always be 100% accurate.